完全切除的pIIIA-N2非小细胞肺癌术后放疗的真实世界实践:中国放射肿瘤科医师全国调查
该全国横断面调查纳入484名经认证的放射肿瘤科医师,评估Lung ART和PORT-C试验发表前后对中国完全切除pIIIA-N2非小细胞肺癌患者术后放疗实践的影响。试验发表后,仅8.7%不推荐术后放疗,22.3%推荐,69.0%根据风险因素决策,最常考虑的风险因素包括淋巴结外侵犯和最高受累淋巴结站等。多数受访者推荐总剂量50 Gy、靶区为肺残端+同侧肺门+阳性淋巴结区域、肺V20<25%和心脏V30<40%作为剂量约束。
要点
- Lung ART和PORT-C试验发表后,8.7%受访者不推荐术后放疗,22.3%推荐,69.0%根据风险因素决策。
- 最常考虑的风险因素为淋巴结外侵犯、最高受累淋巴结站、清扫纵隔淋巴结站数、阳性纵隔淋巴结站数和手术方式。
- 多数受访者推荐总剂量50 Gy、靶区为肺残端+同侧肺门+阳性淋巴结区域、肺V20<25%、心脏V30<40%。
核心结论
- 大多数中国放射肿瘤科医师根据风险因素尤其是淋巴结站状态,对完全切除的IIIA-N2非小细胞肺癌患者推荐术后放疗。
研究设计与样本
- 通过在线调查服务开展全国横断面调查,采用河流抽样策略自愿招募参与者,在放射肿瘤科医师协会网站和微信公众号推文发布调查链接。
- 调查收集参与者真实姓名以确保为委员会认证的放射肿瘤科医师,共纳入484名放射肿瘤科医师,中位年龄40岁(IQR,35-47)。
主要发现
- 377名(77.9%)参与者为男性,282名(58.1%)具有超过10年的胸部放疗临床经验。
- Lung ART和PORT-C试验发表前,313名(64.7%)受访者推荐术后放疗,11名(2.3%)不推荐,160名(33.1%)根据风险因素决策。
- 两试验发表后,仅42名(8.7%)不推荐术后放疗,108名(22.3%)推荐,334名(69.0%)根据风险因素决策。
- 334名根据风险因素决策的受访者中最常考虑的五个风险因素为:淋巴结外侵犯、最高受累淋巴结站、清扫纵隔淋巴结站数、阳性纵隔淋巴结站数和手术方式。
关键数值与推荐
- 多数受访者推荐总剂量50 Gy。
- 多数受访者推荐靶区为肺残端+同侧肺门+阳性淋巴结区域。
- 多数受访者推荐肺V20<25%和心脏V30<40%作为术后放疗的剂量约束。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Results from Lung ART and PORT-C trials suggest that postoperative radiotherapy (PORT) cannot routinely be recommended as standard treatment in completely resected pIIIA-N2 NSCLC patients, but their effects on the real-world practice of PORT in China remain unclear. METHODS: A national cross-section survey was conducted by using an online survey service. Participants were voluntarily recruited using a river sampling strategy. A link to the survey was posted on websites of radiation oncologist associations and tweets from public WeChat accounts. The survey collected the real names of participants to ensure that they were board-certified radiation oncologists. RESULTS: A total of 484 radiation oncologists were included with a median age of 40 years (IQR, 35-47). A total of 377 (77.9%) participants were male, and 282 (58.1%) had more than 10 years of clinical experience practicing thoracic radiotherapy. Before Lung ART and PORT-C trials were published, 313 (64.7%) respondents recommended PORT, 11 (2.3%) did not recommend it, and 160 (33.1%) reported that they made decisions based on risk factors. After the presentation of two trials, only 42 (8.7%) did not recommend PORT, while 108 (22.3%) recommended it, and 334 (69.0%) made decisions based on risk factors. The five most commonly considered risk factors among these 334 respondents were as follows: nodal extracapsular extension, the highest lymph node (LN) station involved, the number of dissected mediastinal LN stations, the number of positive mediastinal LN stations, and surgical approaches. In addition, the majority of all 484 respondents recommended a total dose of 50 Gy, lung stump + ipsilateral hilus + regions containing positive LNs as the targeted region, lung V20 < 25%, and heart V30 < 40% as dose constraints for PORT. CONCLUSION: Most Chinese radiation oncologists recommended PORT for completely resected IIIA-N2 NSCLC patients based on risk factors, especially status of LN station.
引用
- Zhou S, Zhai Y, Zhao K, et al. Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China. Radiat Oncol. 2023. PMID: 36698150. doi:10.1186/s13014-023-02208-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。